![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 53, 37591-37597, December 31, 1999
,
,
From the Centre de Recherche en Cancérologie de
l'Université Laval, Québec G1R 2J6, Canada
The stress-activated protein kinase 2 (SAPK2/p38)
is activated by various environmental stresses and also by a vast array of agonists including growth factors and cytokines. This implies the
existence of multiple proximal signaling pathways converging to the
SAPK2/p38 activation cascade. Here, we show that there is a sensing
mechanism highly specific to heat shock for activation of SAPK2/p38.
After mild heat shock, cells became refractory to reinduction of the
SAPK2/p38 pathway by a second heat shock. This was not the result of a
toxic effect because the cells remained fully responsive to reinduction
by other stresses, cytokines, or growth factors. Neither the activity
of SAPK2/p38 itself nor the accumulation of the heat shock proteins was
essential in the desensitization process. The cells were not
desensitized to heat shock by other treatments that activated
SAPK2/p38. Moreover, inhibiting SAPK2/p38 activity during heat shock
did not block desensitization. Also, overexpression of HSP70, HSP27, or
HSP90 by gene transfection did not cause desensitization, and
inhibiting their synthesis after heat shock did not prevent
desensitization. Desensitization rather appeared to be linked closely
to the turnover of a putative upstream activator of SAPK2/p38.
Cycloheximide induced a progressive and eventually complete
desensitization. The effect was specific to heat shock and minimally
affected activation by other stress inducers. Inhibiting protein
degradation with MG132 caused the constitutive activation of SAPK2/p38,
which was blocked by a pretreatment with either cycloheximide or heat
shock. The results thus indicate that there is a sensing pathway highly
specific to heat shock upstream of SAPK2/p38 activation. The pathway
appears to involve a short lived protein that is the target of rapid
successive up- and down-regulation by heat shock.
Supported by studentships from the Medical Research Council of Canada.
§
To whom correspondence should be addressed: Centre de recherche en
cancérologie de l'Université Laval, L'Hôtel-Dieu de Québec, 11 côte du Palais, Québec G1R 2J6, Canada.
Tel.: 418-691-5555; Fax: 418-691-5439; E-mail:
jacques.landry@med.ulaval.ca.
This article has been cited by other articles:
![]() |
N. Yamamoto, H. Sawada, Y. Izumi, T. Kume, H. Katsuki, S. Shimohama, and A. Akaike Proteasome Inhibition Induces Glutathione Synthesis and Protects Cells from Oxidative Stress: RELEVANCE TO PARKINSON DISEASE J. Biol. Chem., February 16, 2007; 282(7): 4364 - 4372. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dorion, H. Lambert, and J. Landry Activation of the p38 Signaling Pathway by Heat Shock Involves the Dissociation of Glutathione S-Transferase Mu from Ask1 J. Biol. Chem., August 16, 2002; 277(34): 30792 - 30797. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Luss, W. Schmitz, and J. Neumann A proteasome inhibitor confers cardioprotection Cardiovasc Res, April 1, 2002; 54(1): 140 - 151. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |